Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis

American Journal of Nephrology

Volumn 20, Issue 1, 2000, Pages 57-63

  Chin, Ho Jun ^a   Ahn, Curie ^a   Lim, Chun Soo ^a   Chung, Hee Kyoung ^a   Lee, Jung Geon ^a   Song, Yong Wook ^a   Lee, Hyun Soon ^a   Han, Jin Suk ^a   Kim, Suhnggwon ^a   Lee, Jung Sang ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Antilactoferrin antibody; Antineutrophil cytoplasmic antibody; Lupus nephritis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; CREATININE; DNA ANTIBODY; DOUBLE STRANDED DNA; LACTOFERRIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; SINGLE STRANDED DNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOPLASM; DEVICE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WORLD HEALTH ORGANIZATION;

EID: 0033965764     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013557     Document Type: Article

References (23)

1. Falk RJ, Jennette JC: Anti-neutrophil autoantitiodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-1657.
2. Schnabel A, Csernok E, Isenberg DA, Mrowks C, Gross WL: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: Prevalence, specificities, and clinical significance. Arthritis Rheum 1995;38:633-637.
3. Nassberger L: Distribution of antineutrophil cytoplasmic autoantibodies in SLE patients with and without renal involvement. Am J Nephrol 1996;16:548-549.
4. Nishya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K: Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 1997;16:70-75.
5. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A: Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine induced lupus. Clin Exp Immunol 1990;81:380-383.
6. Sinico RA, Pozzi C, Radice A, Tincani A, Li Vecchi M, Rota S, Comotti C, Ferrario F, D'Amico G: Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am J Kidney Dis 1993;22:253-260.
7. Ecklund SR, Saluta GS, Carlos BS, Agudelo A, Pisko EJ, Salem W: Antineutrophil cytoplasmic antibodies: Clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing. South Med J 1992;85:132-138.
8. Lee SS, Lawton JMW: Antimyeloperoxidase antibody in systemic lupus erythematosus. J Intern Med 1992;232:283-286.
9. Zhao MH, Liu N, Zhang YK, Wang HY: Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 1998;13:2821-2824.
10. Konca K, Erken E, Oezbek S: Do antineutrophil cytoplasmic antibodies correlate with disease activity in systemic lupus erythematosus? J Rheumatol 1996;23:2007-2008.
11. Hagen EC, Andrassy K, Chernok E, Daha MR, Gaskin G, Gross W, Lesavre P, Ludemann J, Pusey CD, Rasmussen N, Savage COS, Sinico A, Wiik A, van der Woude JF: The value of indirect immunofluorescence and solid phase techniques for ANCA detection. J Immunol Methods 1993;159:1-16.
12. Merkel PA, Polisson RP, Chang YC, Skates SJ, Niles JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126:866-873.
13. Cambridge G, Wallace H, Bernstein RM, Leaker B: Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994;33:109-114.
14. Wong SN, Shah U, Dillon MJ: Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. Eur J Pediatr 1995;154: 43-45.
15. Pauzner R, Urowitz M, Gladman D, Gough J: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 1994; 21:1670-1673.
16. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Cohen Tervaert JW, Kallenberg CGM: Antineutrophil cryoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 1996;35:625-631.
17. Kuster S, Apenberg S, Andrassy K, Ritz E: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus; in Sessa A. Meroni M, Battini G (eds): Systemic Lupus erythematosus: Renal Vasculitis. 2nd Seminar on Renal Involvement in Systemic Vasculitis, Vimercate, 1991. Basel, Karger, 1992, vol 99, pp 94-98.
18. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC: Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiologic potential. Kidney Int 1994;46:1-15.
19. Lee SS, Lauton JWM, Chan CE, Li CS, Kwan TH, Chau KF: Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 1992;31:669-673.
20. Bennett RM, Davis J: Lactoferrin interacts with deoxyribonucleic acid: A preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes. J Lab Clin Med 1982;99:127-138.
21. Pozzi C, Raduce A, Rota SW, Livecchi M, Sinico R: Clinical significance of antilactoferrin antibodies in renal disease. Am J Kidney Dis 1991;18:202.
22. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, Koolen MI, Hene RJ, The TH, van der Hem GK: Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990;33:1264-1272.
23. Oh YK, Ahn C, Lee SJ, Kim JK, Oh KW, Kim YS, Yun HJ, Han JS, Kim S, Lee JS, Lee HS, Kim YI: Adult glomerulonephritis in Korea: Analysis of 2,001 cases. Korean J Nephrol 1996;15:289-299.